Immunine STIM Plus 600

Immunine STIM Plus 600 is a medicine authorised by Swissmedic under authorisation number 52474. The authorisation holder is Takeda Pharma AG. The medicinal product code is Blood products and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 October 1993 and the authorisation is valid without a time limit. ATC code B02BD04 places the medicine in the group Antihemorrhagics.

Dispensing category B
Authorisation number 52474
ATC B02BD04
Blood products

Authorisation data
Authorisation number	52474
Name	Immunine STIM Plus 600
Full name	Immunine STIM Plus 600, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Authorisation holder	Takeda Pharma AG
Medicinal product code	Blood products
Dispensing category	B · Prescription only
ATC code	B02BD04
First authorisation	06 October 1993
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
3	Immunine STIM Plus 600, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	28 October 1997
4	Immunine STIM Plus 1200, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	B	28 October 1997

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
35		1 Durchstechflasche mit Pulver und 1 Durchstechflasche mit Lösungsmittel und Zubehör	B02BD04	06.01.1.	B
43		1 Durchstechflasche mit Pulver und 1 Durchstechflasche mit Lösungsmittel und Zubehör	B02BD04	06.01.1.	B

Scroll the table sideways

Medicines in the same ATC group

Alprolix 250 IEAuthorisation number 66039 · Swedish Orphan Biovitrum AG · ATC B02BD04B BeneFIX 250Authorisation number 54510 · Pfizer AG · ATC B02BD04B Faktor X P Behring 600 I.E.Authorisation number 47726 · CSL Behring AG · ATC B02BD04B Idelvion 250 IUAuthorisation number 65743 · CSL Behring Lengnau AG · ATC B02BD04B Refixia 500 IEAuthorisation number 66216 · Novo Nordisk Pharma AG · ATC B02BD04B Rixubis 250 IEAuthorisation number 63123 · Takeda Pharma AG · ATC B02BD04B

Other medicines from this authorisation holder

Adcetris 50 mgAuthorisation number 62132 · ATC L01FX05A Advate 250 IE (5 ml)Authorisation number 56352 · ATC B02BD02B Adynovi 250 IE (5 ml)Authorisation number 65953 · ATC B02BD02B Adzynma 500 I.E.Authorisation number 69562 · ATC B01AD13B Agopton 30 mgAuthorisation number 51969 · ATC A02BC03B Alunbrig 30 mgAuthorisation number 66738 · ATC L01ED04A Ceprotin 500 I.E.Authorisation number 56124 · ATC B01AD12B Cinryze 500 IEAuthorisation number 61636 · ATC B06AC01B

Frequently asked questions

Is Immunine STIM Plus 600 authorised in Switzerland?

Yes. Immunine STIM Plus 600 is authorised by Swissmedic under authorisation number 52474, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Immunine STIM Plus 600 have?

Immunine STIM Plus 600 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Immunine STIM Plus 600?

The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.